{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:03:04Z","timestamp":1779915784839,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.autrev.2009.01.017","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T05:14:04Z","timestamp":1233378844000},"page":"563-568","source":"Crossref","is-referenced-by-count":60,"title":["Preventing and curing multiple sclerosis by controlling Epstein\u2013Barr virus infection"],"prefix":"10.1016","volume":"8","author":[{"given":"Michael P.","family":"Pender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2009.01.017_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11882-007-0043-x","article-title":"Immunology of multiple sclerosis","volume":"7","author":"Pender","year":"2007","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.autrev.2009.01.017_bib2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","article-title":"Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases","volume":"24","author":"Pender","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2009.01.017_bib3","series-title":"Infection and autoimmunity","first-page":"163","article-title":"Epstein\u2013Barr virus and autoimmunity","author":"Pender","year":"2004"},{"key":"10.1016\/j.autrev.2009.01.017_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/JVI.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein\u2013Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2009.01.017_bib5","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein\u2013Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.01.017_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.autrev.2007.02.018","article-title":"B cells and herpesviruses: a model of lymphoproliferation","volume":"7","author":"Barozzi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.01.017_bib7","doi-asserted-by":"crossref","first-page":"18093","DOI":"10.1073\/pnas.0509311102","article-title":"Peripheral B cells latently infected with Epstein\u2013Barr virus display molecular hallmarks of classical antigen-selected memory B cells","volume":"102","author":"Souza","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2009.01.017_bib8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein\u2013Barr virus in vivo","volume":"79","author":"Laichalk","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.autrev.2009.01.017_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein\u2013Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2009.01.017_bib10","series-title":"Fields virology","first-page":"2575","article-title":"Epstein\u2013Barr virus","author":"Rickinson","year":"2001"},{"key":"10.1016\/j.autrev.2009.01.017_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(79)90643-3","article-title":"Increased tendency to spontaneous in-vitro lymphocyte transformation in clinically active multiple sclerosis","volume":"314","author":"Fraser","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.01.017_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.1980.00500510052009","article-title":"Epstein\u2013Barr virus antibodies in multiple sclerosis","volume":"37","author":"Sumaya","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/j.autrev.2009.01.017_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2009.01.017_bib14","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","article-title":"High seroprevalence of Epstein\u2013Barr virus in children with multiple sclerosis","volume":"67","author":"Pohl","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2009.01.017_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","article-title":"Association between clinical disease activity and Epstein\u2013Barr virus reactivation in MS","volume":"55","author":"Wandinger","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2009.01.017_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2008.06.008","article-title":"The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders","volume":"7","author":"Ram","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.01.017_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2009.01.017_bib18","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1001\/jama.293.20.2496","article-title":"Temporal relationship between elevation of Epstein\u2013Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis","volume":"293","author":"Levin","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2009.01.017_bib19","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein\u2013Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2009.01.017_bib20","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.WNL.0000130496.51156.D7","article-title":"An altered immune response to Epstein\u2013Barr virus in multiple sclerosis: a prospective study","volume":"62","author":"Sundstr\u00f6m","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2009.01.017_bib21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","article-title":"Identification of Epstein\u2013Barr virus proteins as putative targets of the immune response in multiple sclerosis","volume":"115","author":"Cepok","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2009.01.017_bib22","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.01.017_bib23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(81)91527-0","article-title":"Multiple sclerosis and Epstein\u2013Barr virus","volume":"318","author":"Warner","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.01.017_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/rmv.503","article-title":"Multiple sclerosis is linked to Epstein\u2013Barr virus infection","volume":"16","author":"Haahr","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.autrev.2009.01.017_bib25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-\u03b3 and IL-2","volume":"205","author":"L\u00fcnemann","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.01.017_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2009.01.017_bib27","doi-asserted-by":"crossref","unstructured":"Pender MP, Csurhes PA, Lenarczyk A, Pfluger CMM, Burrows SR. Decreased T-cell reactivity to Epstein\u2013Barr virus-infected lymphoblastoid cell lines in multiple sclerosis. J Neurol Neurosurg Psychiatry, published online 17 November 2008; doi:10.1136\/jnnp.2008.161018.","DOI":"10.1136\/jnnp.2008.161018"},{"key":"10.1016\/j.autrev.2009.01.017_bib28","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(05)60642-3","article-title":"Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis","volume":"351","author":"Pender","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2009.01.017_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(00)00181-8","article-title":"Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis","volume":"105","author":"Van Noort","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2009.01.017_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.162.1.129","article-title":"EBV-induced expression and HLA-DR-restricted presentation by human B cells of \u03b1B-crystallin, a candidate autoantigen in multiple sclerosis","volume":"162","author":"Van Sechel","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2009.01.017_bib31","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/brain\/awn108","article-title":"Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis","volume":"131","author":"Jilek","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2009.01.017_bib32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20050864","article-title":"The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation","volume":"202","author":"Tynan","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2009.01.017_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0090-1229(88)90019-0","article-title":"T-cell-mediated suppression of Epstein\u2013Barr virus-induced B lymphocyte activation in multiple sclerosis","volume":"48","author":"Craig","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2009.01.017_bib34","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2009.01.017_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/505912","article-title":"A mouse monoclonal antibody against Epstein\u2013Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo","volume":"194","author":"Haque","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2009.01.017_bib36","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2009.01.017_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00868517","article-title":"Acyclovir treatment of relapsing\u2013remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study","volume":"243","author":"Lycke","year":"1996","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2009.01.017_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.58.1.31","article-title":"A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS","volume":"58","author":"Bech","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2009.01.017_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2005.02.010","article-title":"siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression","volume":"232","author":"Mei","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.autrev.2009.01.017_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.autrev.2006.08.014","article-title":"What is after cytokine-blocking therapy, a novel therapeutic target\u2014synovial Epstein\u2013Barr virus for rheumatoid arthritis","volume":"6","author":"Sawada","year":"2007","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T16:36:01Z","timestamp":1710002161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997209000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1568997209000226"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2009.01.017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735120627.793556732","asserted-by":"object"}]},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}